Tohru Kambe,Toru Maruyama,Shinsaku Yamane,Satoshi Nakayama,Kousuke Tani
申请号：
US13384383
公开号：
US20120122964A1
申请日:
2010.07.27
申请国别(地区):
US
年份:
2012
代理人:
摘要：
Since a compound represented by the general formula (I) (wherein definition of each group is as described in the specification), a salt thereof, a solvate thereof, or a prodrug thereof has strong and sustaining intraocular pressure lowering activity and, further, has no side effect on eyes such as ocular stimulating property (hyperemia, corneal clouding etc.), aqueous humor protein rise etc., it has high safety, and can be an excellent agent for preventing and/or treating glaucoma etc.
